Accessibility Menu
 
Minerva Surgical logo

Minerva Surgical

(OTC) UTRS

Current Price$0.00
Market Cap$900
Since IPO (2021)-100%
5 YearN/A
1 Year+0%
1 Month+0%

Minerva Surgical Financials at a Glance

Market Cap

$900

Revenue (TTM)

$51.69M

Net Income (TTM)

$35.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

UTRS News

No articles available.

UTRS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Minerva Surgical

Industry

Healthcare Equipment and Supplies

Employees

174

CEO

David M. Clapper

Headquarters

Santa Clara, CA 95054, US

UTRS Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

-61%

Net Income Margin

-68%

Return on Equity

0%

Return on Capital

-57%

Return on Assets

-50%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$900.00

Shares Outstanding

8.88M

Volume

1

Short Interest

0.00%

Avg. Volume

241.917

Financials (TTM)

Gross Profit

$27.24M

Operating Income

$30.90M

EBITDA

$20.07M

Operating Cash Flow

$35.57M

Capital Expenditure

$73.00K

Free Cash Flow

$35.64M

Cash & ST Invst.

$6.94M

Total Debt

$39.69M

Minerva Surgical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$11.96M

-4.9%

Gross Profit

$6.22M

-8.7%

Gross Margin

51.97%

N/A

Market Cap

$900.00

N/A

Market Cap/Employee

$5.17

N/A

Employees

174

N/A

Net Income

$7.18M

+36.6%

EBITDA

$4.56M

+41.4%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$32.43M

-31.2%

Accounts Receivable

$7.57M

+11.5%

Inventory

$18.18M

+6.9%

Long Term Debt

$31.28M

-20.4%

Short Term Debt

$12.27M

+2072.0%

Return on Assets

-49.51%

N/A

Return on Invested Capital

-56.57%

N/A

Free Cash Flow

$5.11M

+24.9%

Operating Cash Flow

$5.09M

+25.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MMTCMicro Imaging Technology, Inc.
$0.00+0.00%
AMHDHLK Biotech Holding Group, Inc.
$0.00+0.00%
EFTReFFECTOR Therapeutics, Inc.
$0.00+0.00%
LITHBioELife Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ANNAAleAnna
$7.22+0.91%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.17-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.72+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.21-0.06%

Questions About UTRS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.